Cargando…
CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma
Autores principales: | Apps, J. R., Stache, C., Gonzalez‐Meljem, J. M., Gutteridge, A., Chalker, J., Jacques, T. S., Forshew, T., Hölsken, A., Martinez‐Barbera, J. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610141/ https://www.ncbi.nlm.nih.gov/pubmed/32125720 http://dx.doi.org/10.1111/nan.12613 |
Ejemplares similares
-
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
por: Carreno, G, et al.
Publicado: (2019) -
BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma
por: Larkin, Sarah Jane, et al.
Publicado: (2014) -
Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis
por: Gonzalez-Meljem, Jose Mario, et al.
Publicado: (2021) -
PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations
por: Cani, Carolina M.G., et al.
Publicado: (2011) -
Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma
por: Martinez‐Barbera, Juan Pedro
Publicado: (2015)